What are OptimizeRx's total assets?

OptimizeRx (OPRX) holds $167.3M in total assets, down 0.3% year over year.

How much debt does OptimizeRx have?

OptimizeRx carries $23.7M in total debt against $129.6M of shareholders' equity, a debt-to-equity ratio of 0.18.

How much cash does OptimizeRx have?

OptimizeRx holds $20.2M in cash and equivalents.

Can OptimizeRx cover its short-term obligations?

Its current ratio is 5.37 — current assets exceed current liabilities.

Where does OptimizeRx's balance sheet data come from?

Every line is extracted from OptimizeRx's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

OptimizeRx OPRX Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Cash and cash equivalents	$20.17M-13.7%	$23.37M+19.7%	$19.52M+17.7%	$16.59M+0.1%	$16.57M+23.9%
Short-term investments	$8.74M+0.9%	$8.66M+1.0%	$8.57M—	——	——
Accounts receivable, net	$31.99M-15.3%	$37.75M+17.1%	$32.23M-3.8%	$33.51M+2.4%	$32.72M-14.4%
Prepaid expenses and other current assets	$3.14M+10.2%	$2.85M+0.7%	$2.83M-15.3%	$3.34M+44.8%	$2.31M-3.1%
Income taxes receivable	$871K+15.8%	$752K-57.0%	$1.75M+170%	$646K+472%	$113K—
Total current assets	$56.17M-13.2%	$64.72M+14.9%	$56.32M+4.1%	$54.08M+4.6%	$51.71M-4.2%
Property and equipment, net	$107K+0.9%	$106K-10.9%	$119K-11.2%	$134K-10.7%	$150K0.0%
Accumulated depreciation	——	——	——	——	——
Operating lease right-of-use assets	3.3%-40,399,997%	40,400,000%+40,399,993%	6.9%0.0%	6.9%+0.9%	6%-36,599,994%
Goodwill	$70.87M0.0%	$70.87M0.0%	$70.87M0.0%	$70.87M0.0%	$70.87M0.0%
Intangible assets, net	$39.75M-2.6%	$40.8M+714%	$5.01M-3.2%	$5.18M-3.1%	$5.35M-3.0%
Deferred tax assets	$5.66M-0.9%	$5.71M+27.0%	$4.49M+29.9%	$3.46M-8.7%	$3.79M-15.7%
Other non-current assets	$110.99M-1.0%	$112.1M-1.6%	$113.88M—	——	——
Total assets	$167.26M-5.5%	$176.92M+3.9%	$170.32M+0.6%	$169.27M+0.9%	$167.77M-2.0%
Accounts payable	$3.07M+87.4%	$1.64M-19.7%	$2.04M+2.8%	$1.98M-41.4%	$3.38M+56.8%
Accrued expenses	$3.59M-69.0%	$11.59M+13.7%	$10.2M-18.4%	$12.49M+34.6%	$9.28M+9.3%
Deferred revenue	$669K+33.0%	$503K+27.3%	$395K-18.4%	$484K-5.3%	$511K+8.0%
Current portion of long-term debt	$2M-53.0%	$4.26M+28.9%	$3.3M0.0%	$3.3M0.0%	$3.3M+65.0%
Operating lease liabilities, current	$177K-8.3%	$193K-6.8%	$207K-1.0%	$209K+50.4%	$139K-17.3%
Total current liabilities	$10.46M-50.8%	$21.26M+15.2%	$18.47M-12.3%	$21.06M+14.7%	$18.35M-1.6%
Long-term debt	$21.34M-0.4%	$21.42M-13.6%	$24.8M-1.3%	$25.13M-13.9%	$29.19M-5.3%
Operating lease liabilities, non-current	$196K-16.2%	$234K-22.0%	$300K-11.5%	$339K+98.2%	$171K-18.2%
Operating Lease Liabilities (Total)	$373K-12.6%	$427K-15.8%	$507K-7.5%	$548K+76.8%	$310K-17.8%
Total liabilities	$37.65M-22.6%	$48.62M+1.2%	$48.06M-3.8%	$49.98M-2.9%	$51.5M-4.9%
Preferred stock	$0—	$0—	$0—	——	——
Common stock	166.7M0.0%	166.7M0.0%	166.7M0.0%	166.7M0.0%	166.7M+833,233%
Additional paid-in capital	$209.32M+0.9%	$207.51M+0.5%	$206.5M+1.1%	$204.3M+0.7%	$202.82M+0.7%
Retained earnings	-$79.73M-0.6%	-$79.24M+6.0%	-$84.26M+0.9%	-$85.04M+1.8%	-$86.57M-2.6%
Treasury stock	$2K0.0%	$2K0.0%	$2K0.0%	$2K0.0%	$2K0.0%
Total stockholders' equity	$129.61M+1.0%	$128.29M+4.9%	$122.26M+2.5%	$119.28M+2.6%	$116.27M-0.6%
Total liabilities and stockholders' equity	$167.26M-5.5%	$176.92M+3.9%	$170.32M+0.6%	$169.27M+0.9%	$167.77M-2.0%
Allowance for Doubtful Accounts	$260K0.0%	$260K0.0%	$260K0.0%	$260K-22.4%	$335K0.0%
Allowance for Doubtful Accounts Receivable (Current)	$260K0.0%	$260K0.0%	$260K0.0%	$260K-22.4%	$335K0.0%
Unbilled Revenue	$4.71M+19.4%	$3.94M+5.9%	$3.72M—	——	——
Finite-Lived Intangible Assets - Expected Amortization Expense (Year One)	——	——	——	——	——
Finite-Lived Intangible Assets - Expected Amortization Expense (Year Five)	——	——	——	——	——
Finite Lived Intangible Assets - Gross	——	——	——	——	——
Net Investment in Lease	$352K-12.9%	$404K-16.0%	$481K-8.9%	$528K+74.3%	$303K-17.2%
Net Operating Loss Carryforwards	——	——	——	——	——
Customer relationships, net	——	——	——	——	——
Intangible assets — net	$39.75M-2.6%	$40.8M+714%	$5.01M-3.2%	$5.18M—	——
Operating lease right-of-use assets	$352K-12.9%	$404K-16.0%	$481K-8.9%	$528K+74.3%	$303K-17.2%
Other Assets	$110.99M-1.0%	$112.1M-1.6%	$113.88M—	——	——
Security deposits and other assets	$18K-35.7%	$28K-70.5%	$95K—	——	——
Patent rights, net	——	——	——	——	——
Technology assets, net	$6.58M-4.3%	$6.87M-6.9%	$7.38M-3.8%	$7.68M—	——
Operating Lease Right-of-Use Assets in Other Assets	$352K-12.9%	$404K-16.0%	$481K-8.9%	$528K+74.3%	$303K-17.2%
Other Commercial Liabilities	$3.59M-69.0%	$11.59M+13.7%	$10.2M-18.4%	$12.49M+34.6%	$9.28M+9.3%
Accrued Liabilities, Current	$3.59M-69.0%	$11.59M+13.7%	$10.2M-18.4%	$12.49M+34.6%	$9.28M+9.3%
Revenue share payable	$955K-69.1%	$3.09M+32.5%	$2.33M-10.1%	$2.59M+48.7%	$1.74M-65.5%
Lease Liability Payments - 2020 (Remaining Three Months)	——	——	——	——	——
Operating Lease Liability Payments - 2024 (Lessee)	——	——	$170K+0.6%	$169K+164%	$64K-44.3%
Operating Lease Liability Payments - 2025 (Lessee)	——	——	$170K+0.6%	$169K—	$0-100%
Lease Liability Payments - Due Year Two	——	——	$170K+0.6%	$169K+164%	$64K-44.3%
Lease Liability Payments - Remainder of Fiscal Year	——	——	$214K+0.5%	$213K+90.2%	$112K-40.4%
Operating Lease Liability Payments Due	——	——	$553K-8.3%	$603K+77.4%	$340K-18.1%
Operating Lease Liability - Undiscounted Excess Amount	——	——	$46K-16.4%	$55K+83.3%	$30K-21.1%
Debt Maturity - 2024	——	——	——	——	——
Debt Maturity - 2027	——	——	$26.29M0.0%	$26.29M-13.2%	$30.29M0.0%
Debt - Unamortized Discount (Premium) and Issuance Costs, Net	$255K-58.5%	$614K-10.9%	$689K-20.2%	$863K-33.6%	$1.3M—
Total debt	$23.72M-9.1%	$26.1M-8.8%	$28.61M-1.3%	$28.98M-11.7%	$32.8M-1.2%
Common Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Common Stock Shares Issued	20.5M0.0%	20.5M+0.8%	20.3M+0.2%	20.3M+0.3%	20.2M—
Convertible Preferred Stock Authorized Shares	10M0.0%	10M0.0%	10M0.0%	10M0.0%	10M0.0%
Convertible Preferred Stock Issued Shares	0—	0—	0—	0—	0—
Convertible Preferred Stock Outstanding Shares	0—	0—	0—	0—	0—
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$21K+5.0%	$20K0.0%	$20K0.0%	$20K0.0%	$20K0.0%
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding	$0—	$0—	$0—	——	——
Treasury Stock, Value	$2K0.0%	$2K0.0%	$2K0.0%	$2K0.0%	$2K0.0%
Preferred Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Share Repurchase Authorization Limit	——	——	——	——	——
Allowance for doubtful accounts	$260K0.0%	$260K0.0%	$260K0.0%	$260K-22.4%	$335K0.0%
Other Commitment	——	——	$1.63M0.0%	$1.63M+1.6%	$1.6M-56.9%
Common stock, par value (in dollars per share)	$00.0%	$00.0%	$00.0%	$00.0%	$00.0%
Common stock, shares authorized (in shares)	$166.67M0.0%	$166.67M0.0%	$166.67M0.0%	$166.67M0.0%	$166.67M0.0%
Common stock, shares issued (in shares)	$20.51M0.0%	$20.5M+0.8%	$20.33M+0.2%	$20.3M+0.3%	$20.23M+0.2%
Common Stock, Shares, Outstanding	$18.77M0.0%	$18.76M+0.9%	$18.59M—	——	——
Other Contractual Commitments - Due in Remainder of 2025	——	——	——	——	——
Deferred income taxes	$5.66M-0.9%	$5.71M+27.0%	$4.49M+29.9%	$3.46M-8.7%	$3.79M-15.7%
Deferred Tax Assets, Operating Loss Carryforwards, State and Local	——	——	——	——	——
Finite-Lived Intangible Assets, Accumulated Amortization	——	——	——	——	——
2028	——	——	——	——	——
2030	——	——	——	——	——
2031	——	——	——	——	——
2027	——	——	——	——	——
2029	——	——	——	——	——
Finite Lived Intangible Assets Amortization Expense After Year Five	——	——	——	——	——
Gross Carrying Amount	——	——	——	——	——
Tax receivable within other current assets	$871K+15.8%	$752K-57.0%	$1.75M+170%	$646K+472%	$113K—
Lessee Operating Lease Liability Payments Due	——	——	$553K-8.3%	$603K+77.4%	$340K-18.1%
Lessee Operating Lease Liability Undiscounted Excess Amount	——	——	$46K-16.4%	$55K+83.3%	$30K-21.1%
Liquidation Basisof Accounting Items Previously Not Recognized	——	——	——	——	——
2028	——	——	$26.29M0.0%	$26.29M-13.2%	$30.29M+1,415%
2029	——	——	——	——	——
2027	——	——	$2M0.0%	$2M0.0%	$2M0.0%
Remainder of 2026	——	——	——	——	——
Operating Lease Weighted Average Discount Rate Percent	——	——	$0.07-0.1%	$0.07+15.0%	$0.06-15.4%
Other Commitment	——	——	$9.61M-26.5%	$13.07M-21.3%	$16.6M-15.9%
Other contractual commitments, Due in 2026 (remainder)	——	——	——	——	——
Preferred Stock, Par or Stated Value Per Share	$00.0%	$00.0%	$00.0%	$00.0%	$00.0%
Preferred Stock, Shares Authorized	$10M0.0%	$10M0.0%	$10M0.0%	$10M0.0%	$10M0.0%
Preferred Stock, Shares Issued	$0—	$0—	$0—	$0—	$0—
Preferred Stock, Shares Outstanding	$0—	$0—	$0—	$0—	$0—
Prepaid expenses	$3.14M+10.2%	$2.85M+0.7%	$2.83M—	——	——
Share Repurchase Program, Authorized, Amount	——	——	——	——	——
Treasury stock, par value (in dollars per share)	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Unamortized Debt Issuance Expense	$255K-58.5%	$614K-10.9%	$689K-20.2%	$863K-33.6%	$1.3M—
Unbilled Receivables	$4.71M+19.4%	$3.94M+5.9%	$3.72M—	——	——
Purchase Obligation	——	——	$9.61M-26.5%	$13.07M-21.3%	$16.6M-15.9%
Remainder of Fiscal Year 2024	——	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about OptimizeRx.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are OptimizeRx's total assets?: OptimizeRx (OPRX) holds $167.3M in total assets, down 0.3% year over year.
How much debt does OptimizeRx have?: OptimizeRx carries $23.7M in total debt against $129.6M of shareholders' equity, a debt-to-equity ratio of 0.18.
How much cash does OptimizeRx have?: OptimizeRx holds $20.2M in cash and equivalents.
Can OptimizeRx cover its short-term obligations?: Its current ratio is 5.37 — current assets exceed current liabilities.
Where does OptimizeRx's balance sheet data come from?: Every line is extracted from OptimizeRx's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.